Aerosolised prostacyclin in adult respiratory distress syndrome

The Lancet

Volumn 342, Issue 8877, 1993, Pages 961-962

  Walmrath, D ^a   Schneider, T ^a   Pilch, J ^a   Grimminger, F ^a   Seeger, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN;

ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ARTICLE; DRUG EFFICACY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AEROSOLS; EPOPROSTENOL; HEMODYNAMICS; HUMAN; MIDDLE AGE; PULMONARY GAS EXCHANGE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0027366628     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)92004-D     Document Type: Article

References (10)

1. 1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange
2. Prostacyclin and right ventricular functions in patients with pulmonary hypertension associated with ARDS
3. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
4. Inhaled nitric oxide for the adult respiratory distress syndrome
5. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
6. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
7. Measurement of continuous distributions of ventilation-perfusion ratios: theory
8. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients
9. The place of prostacyclin in the clinical management of primary pulmonary hypertension
10. Bronchconstrictor and anti-bronchoconstrictor properties of inhaled prostacyclin in asthma